Case File №
#VI-2026-0250
Haikou Mingheng Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
45 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 7 | 6.7 | 5.8 | 8.0 | 3 Oct 2025 |
| Tirzepatide | C Okay | 9 | 6.3 | 4.3 | 8.0 | 11 Jun 2025 |
| 5-amino-1MQ | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| ACE-031 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 21 May 2025 |
| AICAR | X N/A | 1 | 9.1 | 9.1 | 9.1 | 28 Mar 2025 |
| Alprostadil | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| Anadrol Oil | X N/A | 1 | 4.0 | 3.5 | 3.5 | 25 Apr 2025 |
| Andarine S4 | X N/A | 1 | 4.2 | 4.2 | 4.2 | 17 Dec 2024 |
| ARA-290 | X N/A | 1 | 4.9 | 4.9 | 4.9 | 7 May 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| BMK glycidic acid (free acid) CAS 25547-51-7 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 2 Jul 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 6.5 | 6.5 | 6.5 | 3 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 8.4 | 8.4 | 8.4 | 17 Dec 2024 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 |
| DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 20 Jun 2025 |
| Dihexa | X N/A | 1 | 9.8 | 9.8 | 9.8 | 27 Feb 2025 |
| Epithalon | X N/A | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 |
| GHRP-2 Acetate | X N/A | 1 | 6.4 | 6.4 | 6.4 | 2 Apr 2025 |
| HCG | X N/A | 1 | 4.7 | 4.7 | 4.7 | 25 Apr 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X N/A | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 8.3 | 8.3 | 8.3 | 24 Apr 2025 |
| LGD-4033 (Ligandrol) Raw | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Methylene Blue | X N/A | 1 | 5.7 | 5.7 | 5.7 | 2 Apr 2025 |
| MOTS-C | X N/A | 1 | 5.5 | 5.5 | 5.5 | 24 Apr 2025 |
| MT-1 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Jul 2025 |
| NA Semax Amidate | X N/A | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 |
| NAD+ | X N/A | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 |
| NandroMix 300 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 20 Jun 2025 |
| Oxytocin Acetate | X N/A | 1 | 8.1 | 8.1 | 8.1 | 25 Apr 2025 |
| PE 22-28 | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 |
| S-23 Raw | X N/A | 1 | 5.7 | 5.7 | 5.7 | 11 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 6.2 | 6.2 | 6.2 | 11 Jun 2025 |
| Sildenafil (Viagra) | X N/A | 1 | 4.0 | 3.2 | 3.2 | 28 Mar 2025 |
| SNAP-8 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 |
| SR9009 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 2 Apr 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 14 Jan 2025 |
| Test Base (No Ester) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 28 Mar 2025 |
| Testosterone Enanthate Raw | X N/A | 1 | 4.0 | 3.8 | 3.8 | 27 Feb 2025 |
| Thymalin | X N/A | 1 | 9.0 | 9.0 | 9.0 | 13 Feb 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 |
| Trenbolone Enanthate | X N/A | 1 | 6.7 | 6.7 | 6.7 | 8 Jul 2025 |
| TrenMix 200 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 |
| TriTren 225 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 16 Mar 2025 |
Exhibit II
Evidence Log
50 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | PE 22-28 | 8.0 A | 5mg | 5.8mg | +15.8% | 98.84% | vz44q4 | Lab C | Public |
| 24 May 2026 | Trenbolone Enanthate | 7.6 A | 200mg/ml | 200.0mg/ml | +0.0% | 99.86% | a04hpj | Lab C | Public |
| 24 May 2026 | Retatrutide | 7.3 A | 10mg | 10.3mg | +3.0% | 99.60% | (no batch ID) | Lab G | Public |
| 24 May 2026 | NA Semax Amidate | 7.4 A | 2mg | 1.9mg | -3.4% | 97.37% | vl6ctt | Lab A | Public |
| 24 May 2026 | 5-amino-1MQ | 8.4 A | 20mg | 19.5mg | -2.4% | 96.79% | gkw3h2 | Lab E | Public |
| 24 May 2026 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 5.0 B | 250mg/ml | 272.4mg/ml | +9.0% | 99.86% | umt4ce | Lab D | Public |
| 24 May 2026 | Andarine S4 | 5.2 B | 100mg | 91.4mg | -8.6% | 98.22% | 1qjqs0 | Lab A | Public |
| 24 May 2026 | Test Base (No Ester) | 5.5 B | 300mg/ml | 360.5mg/ml | +20.2% | 97.30% | j5n8lw | Lab D | Public |
| 23 May 2026 | Dihexa | 10.0 A | 10mg | 11.2mg | +12.5% | 97.79% | tsm5ej | Lab F | Public |
| 23 May 2026 | ARA-290 | 4.0 C | 20mg | 18.4mg | -8.1% | 97.24% | jxgn5w | Lab B | Community |
| 23 May 2026 | MOTS-C | 7.6 A | 5mg | 4.4mg | -12.9% | 96.26% | v2kyxy | Lab D | Public |
| 21 May 2026 | Tirzepatide | 4.3 D | 15mg | 26.7mg | +78.0% | 99.90% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Tirzepatide | 4.7 D | 10mg | 14.2mg | +42.0% | 99.90% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Tirzepatide | 5.2 C | 20mg | 16.7mg | -16.5% | 99.82% | (no batch ID) | Lab E | Public |
| 21 May 2026 | ACE-031 | 6.2 A | 15mg | 14.7mg | -2.3% | 99.30% | z58wgj | Lab B | Community |
| 21 May 2026 | S-23 Raw | 7.7 A | 5g | 5.2g | +3.5% | 97.61% | 5cw6bf | Lab C | Public |
| 21 May 2026 | TrenMix 200 | 8.5 A | 100mg/ml | 100.7mg/ml | +0.7% | 96.72% | 3wosab | Lab E | Community |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.9 B | 20mg | 24.7mg | +23.7% | 98.15% | kf8b3r | Lab A | Community |
| 20 May 2026 | Retatrutide | 7.0 A | 10mg | 10.5mg | +5.0% | 99.50% | (no batch ID) | Lab G | Public |
| 20 May 2026 | Tirzepatide | 7.8 A | 60mg | 63.3mg | +5.5% | 99.90% | (no batch ID) | Lab G | Public |
| 19 May 2026 | Retatrutide | 8.0 A | 10mg | 10.4mg | +4.0% | 99.90% | (no batch ID) | Lab E | Public |
| 19 May 2026 | Alprostadil | 6.0 A | 50mg | 53.5mg | +6.9% | 99.82% | k99kq4 | Lab A | Public |
| 17 May 2026 | Selank 10mg + Semax 10mg Blend | 8.1 A | 2mg | 2.2mg | +7.6% | 96.31% | a647m8 | Lab D | Community |
| 17 May 2026 | Thymalin | 9.1 A | 15mg | 13.4mg | -10.6% | 97.48% | 754sdv | Lab B | Community |
| 29 Jan 2026 | Anadrol Oil | 6.6 A | 250mg/ml | 233.3mg/ml | -6.7% | 97.27% | vmdi7d | Lab E | Community |
| 29 Jan 2026 | GHRP-2 Acetate | 7.1 A | 50mg | 62.1mg | +24.3% | 95.84% | t1v1jg | Lab C | Community |
| 26 Jan 2026 | BMK glycidic acid (free acid) CAS 25547-51-7 | 7.7 A | 500g | 593.1g | +18.6% | 97.22% | wb3ubf | Lab E | Public |
| 26 Jan 2026 | CJC-1295 With DAC | 6.0 A | 50mg | 57.7mg | +15.5% | 96.62% | th25tl | Lab F | Public |
| 26 Jan 2026 | NAD+ | 10.0 A | 30mg | 32.7mg | +9.0% | 97.55% | hgmfhx | Lab F | Public |
| 26 Jan 2026 | Sildenafil (Viagra) | 5.1 B | 20mg | 19.2mg | -4.1% | 95.41% | hr84xo | Lab E | Public |
| 26 Jan 2026 | TriTren 225 | 9.8 A | 100mg/ml | 119.1mg/ml | +19.1% | 96.14% | wmys1s | Lab E | Public |
| 9 Jan 2026 | Epithalon | 4.4 C | 15mg | 16.4mg | +9.5% | 97.89% | v28q6z | Lab B | Community |
| 9 Jan 2026 | Methylene Blue | 4.1 C | 50mg | 52.4mg | +4.9% | 97.18% | 17216t | Lab G | Public |
| 29 Dec 2025 | HCG | 4.0 C | 50mg | 47.4mg | -5.2% | 95.11% | l2cojk | Lab G | Public |
| 29 Dec 2025 | LGD-4033 (Ligandrol) Raw | 9.2 A | 5g | 4.7g | -5.1% | 96.51% | foom0b | Lab G | Community |
| 5 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.0 A | 2mg | 2.0mg | -0.1% | 98.28% | 480xyn | Lab A | Community |
| 5 Dec 2025 | Testosterone Enanthate Raw | 5.1 B | 500g | 624.9g | +25.0% | 96.69% | 1kvufd | Lab A | Public |
| 23 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 7.0 A | 2mg | 2.3mg | +15.7% | 99.25% | 3bxf7n | Lab G | Public |
| 23 Nov 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.3 A | 2mg | 2.0mg | -0.6% | 95.55% | f9w8b1 | Lab E | Public |
| 23 Nov 2025 | NandroMix 300 | 7.7 A | 100mg/ml | 103.8mg/ml | +3.8% | 98.58% | iv3p8k | Lab E | Community |
| 17 Nov 2025 | Blend 300 (TRA/Mast P/Test P) | 7.8 A | 250mg/ml | 278.7mg/ml | +11.5% | 99.36% | a2gjh2 | Lab F | Community |
| 17 Nov 2025 | Thymosin Alpha-1 | 5.9 B | 20mg | 21.5mg | +7.6% | 95.92% | ixcdx3 | Lab C | Community |
| 14 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.9 B | 30mg | 35.5mg | +18.3% | 98.74% | g1l9ve | Lab G | Community |
| 14 Nov 2025 | Oxytocin Acetate | 10.0 A | 5mg | 5.8mg | +15.4% | 95.48% | pj4xlk | Lab B | Public |
| 14 Nov 2025 | T4 (Levothyroxine) | 5.4 B | 50mg | 53.7mg | +7.4% | 97.08% | pn2bam | Lab E | Public |
| 5 Nov 2025 | AICAR | 9.6 A | 15mg | 13.9mg | -7.5% | 98.21% | jh067w | Lab B | Public |
| 5 Nov 2025 | SR9009 | 5.0 B | 10mg | 9.1mg | -9.2% | 95.08% | x770np | Lab C | Community |
| 17 Oct 2025 | SNAP-8 | 8.1 A | 5mg | 5.3mg | +6.7% | 95.72% | y4aavm | Lab E | Public |
| 9 Oct 2025 | MT-1 | 5.4 B | 5mg | 4.9mg | -2.5% | 97.93% | bm5yud | Lab C | Public |
| 3 Oct 2025 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 5.4 B | 500g | 477.4g | -4.5% | 98.60% | scwtpz | Lab F | Public |
— END OF EVIDENCE LOG —